MUDr. Anna Panovská, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2215, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 106
2024
-
FoxO1/Rictor axis induces a non-genetic adaptation to Ibrutinib via Akt activation in chronic lymphocytic leukemia
The Journal of Clinical Investigation, year: 2024, DOI
-
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
British journal of haematology, year: 2024, volume: 204, edition: 1, DOI
-
Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study
Hematological Oncology, year: 2024, volume: 42, edition: 3, DOI
2023
-
Cílená terapie a imunoterapie u chronické lymfocytární leukemie
Acta medicinae, year: 2023, volume: 2023, edition: 12-13
-
Clonal competition and disrupted molecular processes in chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
-
Complex cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid mylignancies with a focus on targeted analysis of the MECOM gene.
Year: 2023, type: Conference abstract
-
Cytogenetický screening pacientů s chronickou lymfocytární leukémií léčených inhibitorem Brutonovy tyrozinkinázy.
Year: 2023, type: Conference abstract
-
FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.
Year: 2023, type: Conference abstract
-
FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.
Year: 2023, type: Conference abstract
-
Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract